Lipoproteins in Diabetes Mellitus / Contemporary Diabetes (PDF)

Alicia J. Jenkins, MBBS, MD, FRACP, FRCP

NHMRC Clinical Trials Centre, University of Sydney

Medical Foundation Building Level 6

92-94 Parramatta Rd

Camperdown, Sydney, 2050, NSW, Australia



alicia.jenkins@sydney.edu.au







Peter P. Toth, MD, PhD, FCCP, FESC, FAHA, FACC



Department of Medicine, Division of Cardiology




Johns Hopkins University School of Medicine




Baltimore, Maryland

USA



Peter.toth@cghmc.com




Alicia J. Jenkins, MBBS, MD, FRACP, FRCP is an endocrinologist and researcher. She is a Professor of Diabetes and Vascular Medicine at the University of Sydney, Australia and has honorary academic appointments at Universities in the USA, UK and Hong Kong. Her higher research degree and ongoing clinical and research relates to lipoproteins in diabetes, (clinical, biochemical and molecular) biomarkers, and to the prediction and prevention of the complications of diabetes. She and her research team and collaborators undertake clinical and basic research and clinical trials related to diabetes and its complications and to cardiovascular disease. She is a Chief Investigator on several investigator initiated clinical trials in diabetes, including several related to lipid drugs. She has over 400 publications, cited over 10,000 times and an H-index of 53. Alicia has previously worked with Peter Toth to edit the first edition of Lipoproteins in Diabetes Mellitus. Alicia works clinically in Type 1 diabetes clinics and is currently on the International Diabetes Federation Western Pacific Region Executive Council, co-Director of the Australian Cardiovascular Alliance Precision Medicine Flagship, the Lipid Guidelines Committee for the Australian Diabetes Society and President of the diabetes aid organisation Insulin For Life.

Peter P. Toth, MD, PhD is director of preventive cardiology at theCGH Medical Center in